AC BioScience SA

AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne. The company was initiated in 2017 by Andreas Schläpfer and Professor Christian Auclair, a distinguished figure in molecular oncology. AC BioScience is located in the EPFL Innovation Park close to Lausanne and marked its one-year anniversary in March 2018. The start-up recently secured a Fr. 2.50M Seed Round investment on 25 August 2022. With an exceptional business model and visionary mission to revolutionize cancer therapies, AC BioScience demonstrates promising potential within the biotechnology industry.